Teva Pharmaceutical Industries (TEVA) News Today $41.47 +1.50 (+3.75%) Closing price 03:59 PM EasternExtended Trading$41.48 +0.01 (+0.01%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Teva Pharmaceutical Industries Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q3 EarningsOctober 29 at 9:48 AM | finance.yahoo.comTeva Pharmaceutical Industries average analyst price target decreased by 19.51% to ₪33.66October 27 at 11:38 AM | msn.comTeva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience PipelineOctober 27 at 11:38 AM | finance.yahoo.comTeva Pharmaceutical Industries (TEVA) Expected to Release Quarterly Earnings on TuesdayOctober 27 at 8:10 AM | marketbeat.comTeva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience PipelineOctober 27 at 8:00 AM | globenewswire.com106,238 Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Sterling Capital Management LLCOctober 25, 2026 | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Stock Now Rated "Moderate Buy" by Sell-Side BrokeragesOctober 25, 2026 | marketbeat.comTeva Pharmaceutical Industries (TEVA) Secured WELTRUZA Approval, Is It Still 16% Below Fair Value?October 23, 2026 | finance.yahoo.comComparing Teva Pharmaceutical Industries (NYSE:TEVA) and Aytu BioPharma (NASDAQ:AYTU)October 23, 2026 | americanbankingnews.comTeva Pharmaceutical Industries (NYSE:TEVA) Stock Gets Downgrade from Zacks ResearchOctober 22, 2026 | marketbeat.comUEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s DiseaseOctober 20, 2026 | finance.yahoo.comTeva Pharmaceutical Industries (NYSE:TEVA) Given New $47.00 Price Target at BarclaysOctober 15, 2026 | marketbeat.comMedinCell (ENXTPA:MEDCL) Stock Could Be Overvalued On FDA Approval NewsOctober 15, 2026 | finance.yahoo.comJ&J Q3 Earnings Beat Estimates, Sales Miss, View Raised, Stock DownOctober 15, 2026 | finance.yahoo.comNvidia (NVDA) vs. Bumble (BMBL): How the AI Gold Rush is Blinding Investors to Real-Value GemsOctober 15, 2026 | finance.yahoo.comIsrael Elections: AI Stocks, A Defense Winner And Oil Prices In FocusOctober 15, 2026 | finance.yahoo.comTEVA Stock Alert: What to Know as Teva Therapeutics' Scores FDA Approval for Schizophrenia TreamentOctober 12, 2026 | barchart.comTeva to Host R&D Day on Wednesday, November 11 in New York CityOctober 12, 2026 | finance.yahoo.comTeva to Host R&D Day on Wednesday, November 11 in New York CityOctober 12, 2026 | financialpost.comFTeva Pharmaceutical Industries Ltd. to Host R&D Day on November 11, 2026October 12, 2026 | quiverquant.comQTeva to Host R&D Day on Wednesday, November 11 in New York CityOctober 12, 2026 | globenewswire.comTeva Pharmaceutical Industries (NYSE:TEVA) Stock Price Target Raised at JPMorgan Chase & Co.October 12, 2026 | marketbeat.comTeva Pharmaceutical Industries Limited - Depositary receipt price target increased by 22.35% to R$0.35October 12, 2026 | msn.comTEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in SchizophreniaOctober 12, 2026 | finance.yahoo.comTeva Pharmaceutical Industries (TEVA): Transitioning from Generics to High-Margin Branded DrugsOctober 12, 2026 | finance.yahoo.comOppenheimer Adjusts Teva Pharmaceutical Industries PT to $52 From $50, Maintains Outperform RatingOctober 9, 2026 | finance.yahoo.comTeva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives - SlideshowOctober 9, 2026 | seekingalpha.comTeva: 'Hold' On FDA Approval Of Weltruza And Pivot To Growth StrategyOctober 9, 2026 | seekingalpha.comTeva Wins FDA Approval for Monthly Schizophrenia Injectable WELTRUZAOctober 9, 2026 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives TranscriptOctober 9, 2026 | seekingalpha.comTeva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind ApprovalOctober 9, 2026 | finance.yahoo.comTeva Pharmaceutical Industries (NYSE:TEVA) Reaches New 52-Week High - Time to Buy?October 9, 2026 | marketbeat.comTeva shares climb as biosimilar approval and fresh bullish coverage support momentumOctober 9, 2026 | quiverquant.comQTeva wins FDA approval for monthly schizophrenia injection WeltruzaOctober 9, 2026 | reuters.comTeva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with SchizophreniaOctober 9, 2026 | finance.yahoo.comTeva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with SchizophreniaOctober 9, 2026 | globenewswire.comTEVA - Teva Pharmaceutical Industries LimitedOctober 8, 2026 | seekingalpha.comQuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor RelationsOctober 8, 2026 | finance.yahoo.comWhat You Need to Know Ahead of Deckers Outdoor’s Earnings ReleaseOctober 5, 2026 | barchart.comTeva's Ecopipam Shows Sustained Tic Reduction In Pediatric Tourette SyndromeOctober 2, 2026 | rttnews.comConsensus price target for Teva Pharmaceutical Industries raised 24.24% to ₪41.82October 2, 2026 | msn.comTeva Pharmaceutical Industries Ltd: Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette SyndromeOctober 2, 2026 | finanznachrichten.deTeva Pharmaceutical Industries Limited - Depositary receipt price target increased by 19.98% to $0.13October 2, 2026 | msn.comTeva Reports New Efficacy, Safety Data For Ecopipam In Pediatric Tourette SyndromeOctober 2, 2026 | rttnews.comTeva Pharmaceutical Industries Ltd: Journal of Child Neurology Publishes Review Highlighting Dopamine's Role in Tourette Syndrome and Ecopipam's Selective D1 Receptor Mechanism ...October 2, 2026 | finanznachrichten.deJournal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric PatientsOctober 2, 2026 | finance.yahoo.comTeva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette SyndromeOctober 2, 2026 | finance.yahoo.comTeva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette SyndromeOctober 2, 2026 | globenewswire.comJournal of Child Neurology Publishes Review Highlighting Dopamine's Role in Tourette Syndrome and Ecopipam's Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric PatientsOctober 2, 2026 | globenewswire.comBranded Medicines and Pipeline Successes Drive Teva Pharmaceutical Industries’ (TEVA) Margin ExpansionOctober 1, 2026 | insidermonkey.com Teva Pharmaceutical Industries Media Mentions By Week Teva Pharmaceutical Industries Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.380.68▲Average Healthcare News Sentiment Teva Pharmaceutical Industries News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼89▲TEVA Articles Average Week Teva Pharmaceutical Industries Trends on MarketBeatThis week vs. last weekNew Followers4+100%Searches4-33%Page Views4,010-5% Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ABBV News NVO News PFE News BMY News GSK News SNY News TAK News ONC News RPRX News ZTS News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Teva Pharmaceutical Industries dated 10/29/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe "velvet rope" stock setups hiding from regular indicatorsK.I.R.A. is a new trading engine built to flag market setups before they show up on standard charts. Former...The TradingPub | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredxIn 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't whole again un...USA Capital Gold | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredThe Claude AI company doubled in value... you missed itIn May, Anthropic raised money at a $965 billion valuation. Now, ahead of its IPO, investors are reportedly di...Crypto 101 Media | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"In 2025, the dollar lost 12% in value. Real inflation hit 5%+. 12% + 5% = 17% purchasing power gone. And it's ...Decentralized Masters | SponsoredA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Withou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
